Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mirochnick

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
HIV Medicine|November 20, 2014
Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokineticsF T Aweeka, C Hu, L Huang, et al.
The Journal of Infectious Diseases|August 11, 1998
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 TeamM Mirochnick, T Fenton, P Gagnier, et al.
AIDS (London, England)|October 16, 2001
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)S H Eshleman, M Mracna, L A Guay, et al.
Clinical Pharmacology and Therapeutics|July 14, 2001
Population pharmacokinetics of dapsone in children with human immunodeficiency virus infectionM Mirochnick, E Cooper, E Capparelli, et al.
HIV Medicine|December 2, 2011
Effect of pregnancy on emtricitabine pharmacokineticsA M Stek, B M Best, W Luo, et al.
HIV Medicine|May 12, 2015
Pharmacokinetics of tenofovir during pregnancy and postpartumB M Best, S Burchett, H Li, et al.
HIV Medicine|September 1, 2007
Pharmacokinetics of oral zidovudine administered during labour: a preliminary studyM Mirochnick, J H Rodman, B L Robbins, et al.
HIV Clinical Trials|May 14, 2008
Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353Y J Bryson, M Mirochnick, A Stek, et al.
HIV Medicine|September 18, 2008
Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartumJ S Read, B M Best, A M Stek, et al.
The Pediatric Infectious Disease Journal|June 3, 1999
Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials GroupK McIntosh, E Cooper, J Xu, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
HIV Medicine|November 20, 2014
Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokineticsF T Aweeka, C Hu, L Huang, et al.
The Journal of Infectious Diseases|August 11, 1998
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 TeamM Mirochnick, T Fenton, P Gagnier, et al.
AIDS (London, England)|October 16, 2001
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)S H Eshleman, M Mracna, L A Guay, et al.
Clinical Pharmacology and Therapeutics|July 14, 2001
Population pharmacokinetics of dapsone in children with human immunodeficiency virus infectionM Mirochnick, E Cooper, E Capparelli, et al.
HIV Medicine|December 2, 2011
Effect of pregnancy on emtricitabine pharmacokineticsA M Stek, B M Best, W Luo, et al.
HIV Medicine|May 12, 2015
Pharmacokinetics of tenofovir during pregnancy and postpartumB M Best, S Burchett, H Li, et al.
HIV Medicine|September 1, 2007
Pharmacokinetics of oral zidovudine administered during labour: a preliminary studyM Mirochnick, J H Rodman, B L Robbins, et al.
HIV Clinical Trials|May 14, 2008
Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353Y J Bryson, M Mirochnick, A Stek, et al.
HIV Medicine|September 18, 2008
Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartumJ S Read, B M Best, A M Stek, et al.
The Pediatric Infectious Disease Journal|June 3, 1999
Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials GroupK McIntosh, E Cooper, J Xu, et al.
Pageof 4